Results 11 to 20 of about 37,478 (219)
Background: Hepsin (HPN), a type II trans-membrane serine protease, has been reported to be one of the most up regulated genes in prostate cancer. The aim of the present study was to find out immuno-histochemistry based phenotypic expression of HPN in ...
Madhu Mati Goel +3 more
doaj +1 more source
Treatment options in benign prostate hyperplasia associated with lower urinary tract symptoms
Benign prostatic hyperplasia is a common cause of lower urinary tract symptoms. Men who are treated for benign prostatic hyperplasia potentially reduce their lifetime risk of acute urinary retention and the need for benign prostatic hyperplasia-related ...
Ali Atan, Altuğ Tuncel
doaj +1 more source
TRANSURETHRAL THULIUM:YAG LASER VAPOENUCLEATION IN BENIGN PROSTATIC HYPERPLASIA TREATMENT
Objectives. The aim of the study was to analyze evidence based data from existing sources, regarding the role and the efficacy of transurethral Thulium:YAG laser vapoenucleation in benign prostatic hyperplasia treatment. Material and methods.
Alexei Pleșacov +2 more
doaj +3 more sources
This work investigated the spectrum-effect relationships between high performance liquid chromatography (HPLC) fingerprints and the anti-benign prostatic hyperplasia activities of aqueous extracts from Saxifraga stolonifera.
Xing-Dong Wu +8 more
doaj +1 more source
Background: To treat symptomatic benign prostatic hyperplasia α1-adrenoceptor antagonists with little antagonism at α1b-adrenoceptor were used to avoid orthostatic hypotension.
B Acharya +5 more
doaj +1 more source
Role of gangliosides in prostate pathology [PDF]
Molecular pathology of benign prostatic hyperplasia is multifactorial and involves endocrine, biochemical, immunological interactions. The mechanisms involved in the onset and progression of benign prostatic hyperplasia are: infections, 50 years of age ...
Ilinca Nicolae +2 more
doaj +1 more source
Background: To investigate the effect of asymptomatic inflammatory prostatitis on clinical outcomes of patients undergoing trans urethral resection of prostate due to benign prostatic hyperplasia.
Suleyman Sami Cakir +5 more
doaj +1 more source
Testosterone undecanoate is a hormone agent with long-acting potential and is used for testosterone replacement therapy for hypogonadism. This study was designed to investigate application of testosterone undecanoate in maintaining high androgen levels ...
Jinho An, Hyunseok Kong
doaj +1 more source
Treatment of Benign Prostatic Hyperplasia [PDF]
Lower urinary tract symptoms (LUTS) may be a sign of aging rather than a consequence of benign prostatic enlargement (BPE) or benign prostatic obstruction (BPO). Medical or invasive treatments should address the bothersome symptoms and the quality of life of patients.
Luís Campos, Pinheiro +1 more
openaire +2 more sources
Effect of Educational Guidelines Application on Quality of life among Geriatric Patients having Benign Prostatic Hyperplasia [PDF]
Background: Benign prostatic hyperplasia is one of the most prevalent disorders in elderly men and non-malignant condition of the prostate, increases morbidity, often resulting in lower urinary tract symptoms, which can have an undesirable influence on a
Laila Awadin Ali Hassan +5 more
doaj +1 more source

